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Background: Methadone-associated sudden death is a leading public health issue. High plasma methadone concentration (PMC) and QTc interval 
prolongation increase risk for sudden death. We examined clinical, genetic and pharmacokinetic variables and methadone dose for associations with 
plasma methadone concentrations and QTc prolongation.
methods: Consenting participants (n=31) initiating methadone maintenance therapy were enrolled in the MEMORIES Trial (Clinical Trials.gov 
NCT01191242). Peak (4 hr post-oral dose) and trough (24 hr) plasma samples obtained on days 1, 7 and 21 were analyzed for methadone and 
EDDP (the principal methadone metabolite) by liquid chromatographic tandem mass spectrometry. Pre-treatment and d21 rate-corrected QT interval 
(QTc) was measured by ECG.
results: PMC was associated with dose and body mass index, although 60.4% of PMC variability was unexplained by dose. Variants in ABCB1, 
CYP3A4 and CYP2B6 genes were not predictive of PMC; however, stereo-selectivity of CYP2B6 was reduced by the variant rs3745274. Baseline QTc 
did not predict day (d) 21 QTc (r2=0.056, p=0.25); however d21 trough plasma EDDP was highly correlated with QTc (r2=0.386, p=0.001). For 
subjects with d21 QTc ≥447msec (n=6), d21 trough EDDP was 43.8±15.4 ng/mL vs 22.9±10.7ng/mL for QTC<447msec, p=0.004). Findings were 
similar on d 8 (r2=0.197, p=0.026; 104.4 ±36.7 ng/mL and 70.2 ±26.1 ng/mL for QTc ≥ and <447msec, respectively, p<0.02). Trough EDDP ≥25 
ng/mL predicted day 21 QTc≥447 msec, with sensitivity of 100% and specificity of 78.9%.
conclusions: Individual response to oral methadone is highly variable and incompletely explained by dose or currently known clinical and genetic 
variables. Variables, presently unknown, may account for the remainder of inter-individual variability. Methadone-increased QTc interval directly 
correlated with plasma trough level EDDP as early as d8 and, at d21, identified with 100% sensitivity those with QTc ≥447msec. The use of EDDP 
appears promising as a risk marker for QTc prolongation and deserves further study. 
